Pneumatic Nebulizers Market Size, Share & Trends Analysis Report By Indication (Breath-actuated, Vented), By End-use (Hospitals & Clinics, Home Healthcare), By Region, And Segment Forecasts, 2025 - 2030

Pneumatic Nebulizers Market Size & Trends

The global pneumatic nebulizers market size was valued at USD 804.14 million in 2024 and is expected to grow at a CAGR of 6.5% from 2025 to 2030. Increasing incidence of chronic respiratory diseases, rising demand for home healthcare devices, and growing geriatric population are expected to drive the market. Moreover, increased strategic initiatives by organizations also contributing to the market growth. For instance, Omron, as mentioned in its Integrated Report 2022, emphasizes strengthening its nebulizer product lineup to meet the high market demand.

The rising prevalence of chronic respiratory diseases is expected to drive the market. For instance, according to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, which caused 3.3 million deaths in 2019. Around 90% of deaths caused were especially in low and middle-income countries. Furthermore, according to statistics published by the Asthma and Allergy Foundation of America in April 2024, approximately 27 million people in the U.S. have asthma.  Moreover, the easy availability of compact pneumatic nebulizers ideal for home use and technological innovations in these devices such as noise reduction and improved functionality are increasing their adoption in-home healthcare.

The COVID-19 pandemic significantly impacted the pneumatic nebulizer market. During the pandemic, there was a notable shift in treatment preferences among patients and healthcare providers. Many asthma and COPD patients were initially hesitant to use nebulizers due to concerns about airborne transmission of viruses through aerosolized medications. However, medical professionals advised these patients to continue using their prescribed inhaled medications, including nebulizers, which ultimately increased their importance in respiratory care. Moreover, the pandemic also caused significant disruptions in global supply chains, affecting the production and distribution of nebulizers. Manufacturing delays and component shortages impacted the availability of these devices in various markets. 

Market Concentration & Characteristics

The degree of innovation in the industry is high. Improvements in nebulization efficiency through optimized jet designs have enhanced drug delivery effectiveness. The introduction of smart nebulizers equipped with connectivity features allows for remote monitoring and data collection, further driving market growth by enabling healthcare providers to track patient adherence and outcomes effectively.

The industry's level of partnerships & collaborations is moderate. This is owing to the desire to gain a competitive advantage in the industry, enhance technological capabilities, and the need to consolidate in a rapidly growing market. According to the article published in October 2022 by News Today, AeroRx Therapeutics collaborated with HCmed Innovations to discover a new therapeutic combination of different classes of medications (bronchodilators) that helps in opening the airways to ease breathing to treat the patient with chronic pulmonary disease (COPD).

Health authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) govern the regulatory landscape for jet nebulizers. These organizations set stringent guidelines to ensure that nebulizers are safe and effective for patient use. The FDA classifies nebulizers as Class II medical devices requiring premarket notification 510(k).

The industry's regional expansion is moderate, driven by an increasing demand for pneumatic nebulizers in the emerging nations. These nebulizers are traditional, cost-effective, and proven efficient, making them a preferred choice in developing countries. 

Indication Insights

Based on indication, the breath-actuated segment held the largest revenue share 64.06% in 2024. Breath-actuated nebulizers elucidate higher drug delivery capacity and lesser dosage wastage features. Thus, the segment delivering advanced inhalation therapy is expected to dominate the market over the forecast period. For instance, in June 2024, Verona Pharma plc, a partner of Ligand Pharmaceuticals Incorporated, received U.S. FDA approval for Ohtuvayre, which can be directly delivered to the lungs through a pneumatic nebulizer.

The vented segment is anticipated to grow at the fastest CAGR over the forecast period due to its efficiency in delivering aerosolized medication directly to the lungs. As healthcare providers seek to improve patient outcomes, vented nebulizers are preferred for their ability to provide consistent medication delivery while minimizing waste. This trend is further supported by advancements in nebulizer technology that enhance performance, such as improved compressor designs and optimized aerosol generation techniques. Consequently, these innovations boost patient compliance and drive market growth as healthcare systems increasingly adopt these devices.

End-use Insights

Hospitals & clinics segment held the largest market share in 2024. The increasing adoption of pneumatic nebulizers for the management of acute respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) is fueling the segment growth. Moreover, the need for rapid treatment options in emergency departments, where time-sensitive interventions demand the increased adoption of these devices, significantly impacting treatment outcomes.

Furthermore, with a growing emphasis on outpatient care and preventive health measures, clinics are increasingly adopting pneumatic nebulizers to manage chronic respiratory conditions among their patients. In addition, collaborations between manufacturers and healthcare facilities are facilitating innovation in device design and functionality, ultimately improving patient adherence to prescribed therapies. Such factors are expected to fuel the market growth over the forecast period.

The home healthcare segment is expected to grow at the fastest CAGR from 2025 to 2030. The rise of telemedicine has facilitated remote monitoring of patients using nebulizers at home, further driving demand for these devices within home healthcare settings. This trend is further supported by healthcare policies that promote home healthcare services as part of integrated care pathways.

Regional Insights

North America pneumatic nebulizers market dominated with a revenue share of 35.3% in 2024 and is poised to grow over the forecast period owing to the increasing prevalence of respiratory diseases and advancements in nebulizer technology. Moreover, the growing geriatric population susceptible to respiratory diseases is also contributing to the market growth.

U.S. Pneumatic Nebulizers Market Trends

The U.S. pneumatic nebulizers market held the largest revenue share in 2024. This is attributed to the rising prevalence of chronic respiratory diseases and technological advancements. According to statistics from the Asthma and Allergy Foundation of America, approximately 25 million people in the U.S. suffer from asthma. Moreover, the presence of robust healthcare infrastructure, rising healthcare expenditures, and an increasing geriatric population are expected to drive the market further.

Europe Pneumatic Nebulizers Market Trends

Europe Pneumatic nebulizers market is poised to grow over the forecast period due to the robust healthcare infrastructure, technological advancements, growing geriatric population, and rising prevalence of respiratory diseases.

The pneumatic nebulizers market in the UK is expected to grow significantly over the forecast period due to the rising prevalence of lung cancer, and other respiratory disorders. For instance, according to the NHS, every year, around 43,000 people are diagnosed with lung cancer in the country. Moreover, favorable government policies further fuel market growth. The nebulizers are covered under various healthcare plans, encouraging their adoption among patients requiring long-term management of respiratory conditions. In addition, the presence of favorable reimbursement policies enhances accessibility to these devices.

The pneumatic nebulizer market in Germany is expected to grow substantially over the forecast period, owing to rising healthcare expenditures, strong regulatory support, and the rising prevalence of chronic respiratory diseases.

Asia Pacific Pneumatic Nebulizers Market Trends  

Asia Pacific is expected to grow at the fastest CAGR over the forecast period. The burden of COPD in Asia is greater than that in developed Western countries. In Japan, 90% of COPD patients reported a strong smoking history. Moreover, a significant rise in the geriatric population in Japan is driving the product demand in the country, thereby supporting regional growth.

The pneumatic nebulizer market in China is poised to grow substantially over the forecast period, owing to the increasing prevalence of respiratory diseases, technological advancements, rising geriatric population, and growing government initiatives and healthcare investments.  The development and introduction of advanced pneumatic nebulizers that are more portable, efficient, and user-friendly have contributed to their increased adoption among patients. Moreover, the presence of both local and international manufacturers in the country is also contributing to the market growth as these players engage in strategic initiatives to strengthen their market position.

The pneumatic nebulizers market in India is experiencing significant growth, driven primarily by the increasing prevalence of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. The rising pollution levels in urban areas have augmented these health issues, leading to a higher demand for effective treatment options like pneumatic nebulizers.

Latin America Pneumatic Nebulizers Market Trends  

The pneumatic nebulizers market in Latin America is experiencing growth due to several factors, including the rising prevalence of respiratory diseases, increasing demand for home healthcare devices, and technological advancements.

Pneumatic nebulizers market in Brazil is expected to grow over the forecast period, owing to the rising incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. For instance, according to a recent study published in the PubMed Journal in March 2024, the prevalence of connective tissue disease-associated interstitial lung disease is the most frequent in the country, followed by hypersensitivity pneumonitis and idiopathic pulmonary fibrosis. Thus, as more individuals are diagnosed with respiratory ailments, there is an escalating demand for effective treatment options, thereby boosting market growth.

Middle East & Africa Pneumatic Nebulizers Market Trends

The pneumatic nebulizers market in the Middle East & Africa (MEA) is experiencing growth, driven by the rising prevalence of respiratory diseases and increasing healthcare expenditure. For instance, according to a study published in the PMC Journal in September 2022, chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and other related conditions were found to be a leading cause of morbidity and mortality in the region. Factors contributing to this high prevalence include outdoor pollution, household and ambient particulate matter pollution, and tobacco smoking. Moreover, due to their cost-effectiveness and proven efficacy, pneumatic nebulizers are a preferred choice for the treatment of COPD in the region.

The pneumatic nebulizers market in Saudi Arabia is experiencing growth, driven by the increasing prevalence of respiratory diseases, growing geriatric population, advancements in medical technology, and heightened awareness regarding respiratory health. Moreover, increasing healthcare expenditure is also expected to drive market growth further.

Key Pneumatic Nebulizers Company Insights

The market is fairly competitive, with the presence of key players such as Koninklijke Philips N.V. and OMRON Corporation. Key players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge in the market.

Recent Developments

• In May 2024, Medline launched a small-volume nebulizer, Hudson RCI TurboMist, that delivers medication in just three minutes.

 “Respiratory therapists are constantly adapting and innovating to solve challenges to better care for patients, and we strive to innovate right beside them in order to strengthen the respiratory therapy sector. Over the years, we have developed robust solutions to meet every respiratory need, from hospital to home,”

-James Donegan, a registered respiratory therapist and Medline clinical specialist.

“We believe that our newest solution, TurboMist, will fulfill a need in the market to drive efficiencies with shorter medication delivery times and an enhanced patient experience.”

Pneumatic Nebulizers Market Report Scope

Global Pneumatic Nebulizers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pneumatic nebulizers market report based on indication, end-use, and region:

• Indication Outlook (Revenue, USD Million, 2018 - 2030)

  • Breath-actuated

  • Vented

• End-use Outlook (Revenue, USD Million, 2018 - 2030) 

  • Hospitals & Clinics    

  • Home Healthcare

• Regional Outlook (Revenue, USD Million, 2018 - 2030) 

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Norway

    • Denmark

    • Sweden

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait